Iridex to Present at the Sidoti Year-End Virtual Investor Conference

Iridex (NASDAQ: IRIX) will participate in the Sidoti Year-End Virtual Investor Conference with management presenting on Thursday, December 11, 2025 at 10:45 AM ET.

Rhea-AI Summary

Iridex (NASDAQ: IRIX) will participate in the Sidoti Year-End Virtual Investor Conference with management presenting on Thursday, December 11, 2025 at 10:45 AM ET. Interested parties can access a live and archived webcast via the company’s Investor Relations Event Calendar at www.IRIDEX.com. The presentation provides investors a direct opportunity to hear company updates and ask questions during the scheduled webcast.

Argus Dec 5 session

+1.17% close to close Open Argus

Details

News Market Reaction – IRIX

In the Dec 5 session, IRIX gained 1.17%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights IRIDEX’s participation in the Sidoti Year-End Virtual Investor Conferen...

Analysis

This announcement highlights IRIDEX’s participation in the Sidoti Year-End Virtual Investor Conference on December 11 at 10:45 am ET, reinforcing its ongoing investor outreach following recent Q2 and Q3 2025 results and restored Nasdaq listing compliance. Investors may track how management frames revenue growth, margin trends, and capital position discussed in prior filings, while also watching subsequent earnings releases and regulatory disclosures for further validation of the company’s trajectory.

Key Figures

Conference date: December 11, 2025 Presentation time: 10:45 am ET

Conference date

December 11, 2025

Scheduled Sidoti Year-End Virtual Investor Conference presentation date

Presentation time

10:45 am ET

Scheduled time for management presentation at Sidoti conference

Historical Context

5 past events · Latest: Nov 11

5 events

1. Nov 11

   Q3 earnings

   24h Move

   +8.2%

   Q3 2025 revenue growth with improved adjusted EBITDA and lower operating expenses.

2. Oct 28

   Earnings scheduling

   24h Move

   +2.0%

   Announcement of Q3 2025 results release and investor conference call timing.

3. Sep 09

   Nasdaq compliance

   24h Move

   -2.8%

   Formal notification of regained compliance with Nasdaq equity listing requirements.

4. Aug 12

   Q2 earnings

   24h Move

   -9.2%

   Q2 2025 results with net loss and lower gross margin despite revenue growth.

5. Jul 29

   Earnings scheduling

   24h Move

   -0.7%

   Scheduling of Q2 2025 results release and associated investor conference call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MOUNTAIN VIEW, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to participate in the upcoming Sidoti Year-End Virtual Investor Conference.

Management is scheduled to present on Thursday, December 11 at 10:45 am ET. Interested parties may access a live and archived webcast of the presentation on the “Event Calendar” page of the “Investors” section of the company’s website at www.IRIDEX.com.

About Iridex Corporation 
Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, which include capital equipment and consumable probes for the ophthalmology market. The Company’s proprietary MicroPulse^® technology delivers the therapeutic benefits of laser treatment while minimizing tissue damage, offering a safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases. Iridex products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the Iridex website at www.iridex.com.

Investor Relations Contact

Philip Taylor
Gilmartin Group
investors@iridex.com

Media Contact
Joan Stauffer
jstauffer@iridex.com

For more information about Iridex technologies, visit www.iridex.com.

Iridex, the Iridex logo, MicroPulse^®, the MicroPulse logo, Cyclo G6, MicroPulse P3^®, and G-Probe^® are registered trademarks of Iridex. ©2025 Iridex Corporation. All rights reserved.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Iridex (IRIX) present at the Sidoti Year-End Virtual Investor Conference in 2025?

Iridex management will present on Thursday, December 11, 2025 at 10:45 AM ET.

How can investors watch the Iridex (IRIX) Sidoti conference presentation on December 11, 2025?

Investors can view the live and archived webcast from the Event Calendar in the Investors section at www.IRIDEX.com.

Will the Iridex (IRIX) Sidoti presentation be available after the live event?

Yes; an archived webcast will be available on the company’s Investor Relations Event Calendar at www.IRIDEX.com.

What topics will Iridex (IRIX) management cover at the Sidoti Year-End Virtual Investor Conference?

The company announced management will present company updates; specific topics were not detailed in the announcement.

Is registration required to attend Iridex (IRIX) Sidoti webcast on December 11, 2025?

The announcement notes viewers may access the live webcast via the Investor Relations Event Calendar; check the Event Calendar for any registration details.

Where on IRIDEX.com can I find the Sidoti Year-End Virtual Investor Conference webcast for IRIX?

The webcast will be posted on the Event Calendar page within the Investors section of www.IRIDEX.com.